• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶催化的结直肠癌中的蛋白水解作用。

Plasmin-catalyzed proteolysis in colorectal neoplasia.

作者信息

Delbaldo C, Cunningham M, Vassalli J D, Sappino A P

机构信息

Division of Oncology, University of Geneva Medical School, Switzerland.

出版信息

Cancer Res. 1995 Oct 15;55(20):4688-95.

PMID:7553650
Abstract

The expression of different components of the plasminogen activator (PA)/plasmin system was explored in a series of colorectal neoplasia. We have found that urokinase (uPA) and urokinase receptor (uPA-R) gene expression is upregulated in adenomas and carcinomas, and that uPA/uPA-R production is confined to stromal cells in the proximity of epithelial proliferations. In addition, in adenomas, the focal increase in uPA mRNA is not systematically coupled to detectable enzymatic activity, whereas in carcinomas, uPA mRNA accumulation is consistently associated with detectable but variable levels of enzymatic activity. In contrast, in the tumor vasculature, tissue-type plasminogen activator-mediated proteolysis is considerably reduced when compared to normal mucosal and submucosal vessels; this reduction in plasmin formation appears to result from the highly increased production of plasminogen activator inhibitor type 1 by endothelial cells. Our observations demonstrate that colorectal neoplasia are associated with marked alterations in the extracellular proteolytic balance controlled by the PA/plasmin system. They show that contrasting disturbances in plasmin formation take place in distinct stromal compartments but not in epithelial cells, and that these disturbances are maximal during invasive neoplasia. Altogether, our results raise the possibility that alterations in plasmin formation should not be exclusively regarded as promoters of cancer cell invasiveness.

摘要

在一系列结直肠肿瘤中,对纤溶酶原激活物(PA)/纤溶酶系统不同组分的表达进行了研究。我们发现,尿激酶(uPA)和尿激酶受体(uPA-R)基因表达在腺瘤和癌中上调,且uPA/uPA-R的产生局限于上皮增殖附近的基质细胞。此外,在腺瘤中,uPA mRNA的局灶性增加并非总是与可检测到的酶活性相关,而在癌中,uPA mRNA的积累始终与可检测到但水平可变的酶活性相关。相比之下,在肿瘤脉管系统中,与正常黏膜和黏膜下血管相比,组织型纤溶酶原激活物介导的蛋白水解作用显著降低;纤溶酶形成的这种减少似乎是由于内皮细胞中纤溶酶原激活物抑制剂1的产生大量增加所致。我们的观察结果表明,结直肠肿瘤与PA/纤溶酶系统控制的细胞外蛋白水解平衡的显著改变有关。结果显示,纤溶酶形成的相反紊乱发生在不同的基质区室而非上皮细胞中,且这些紊乱在侵袭性肿瘤形成过程中最为明显。总之,我们的结果提出了一种可能性,即纤溶酶形成的改变不应仅仅被视为癌细胞侵袭性的促进因素。

相似文献

1
Plasmin-catalyzed proteolysis in colorectal neoplasia.纤溶酶催化的结直肠癌中的蛋白水解作用。
Cancer Res. 1995 Oct 15;55(20):4688-95.
2
In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.尿激酶/纤溶酶系统的原位基质表达与大肠腺瘤中的上皮发育异常相关。
Am J Pathol. 1997 Jan;150(1):283-95.
3
THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.通过增加尿激酶和尿激酶受体的表达,转化生长因子-β1上调THP-1巨噬细胞膜结合纤溶酶活性。
J Cell Physiol. 1995 Aug;164(2):334-43. doi: 10.1002/jcp.1041640214.
4
Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.乳腺癌细胞表面的纤溶酶原结合与激活:尿激酶活性的重要作用。
Breast Cancer Res. 2007;9(1):R14. doi: 10.1186/bcr1647.
5
Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体及其抑制剂在春季角结膜炎中的作用
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70. doi: 10.1167/iovs.04-1196.
6
Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.前列腺素E2调节大鼠颅骨成骨细胞原代培养物中纤溶酶原激活物同工酶、尿激酶受体和纤溶酶原激活物抑制剂-1的产生。
J Cell Physiol. 1995 Dec;165(3):521-9. doi: 10.1002/jcp.1041650310.
7
The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).一种人角质形成细胞系(HaCaT)的尿激酶型纤溶酶原激活剂受体。
Exp Cell Res. 1994 Oct;214(2):486-98. doi: 10.1006/excr.1994.1286.
8
Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.与尿激酶、其受体和纤溶酶原激活物抑制剂-1不同,上皮组织型纤溶酶原激活物的表达在慢性静脉溃疡中增加。
Br J Dermatol. 2004 Dec;151(6):1189-96. doi: 10.1111/j.1365-2133.2004.06261.x.
9
Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.月经周期中子宫内膜组织中尿激酶型纤溶酶原激活剂(uPA)、其受体(uPAR)及其抑制剂(PAI-1)mRNA和蛋白的差异定位与表达。
Mol Hum Reprod. 2004 Sep;10(9):655-63. doi: 10.1093/molehr/gah081. Epub 2004 Jul 8.
10
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.格尔德霉素是肝细胞生长因子/分散因子-甲硫氨酸-尿激酶型纤溶酶原激活剂-纤溶酶蛋白水解网络的强效抑制剂。
Cancer Res. 2000 Jan 15;60(2):342-9.

引用本文的文献

1
Enhanced activity of meprin-α, a pro-migratory and pro-angiogenic protease, in colorectal cancer.基质金属蛋白酶-α活性增强与结直肠癌的迁移和血管生成。
PLoS One. 2011;6(11):e26450. doi: 10.1371/journal.pone.0026450. Epub 2011 Nov 11.
2
Cell surface molecules and their prognostic values in assessing colorectal carcinomas.细胞表面分子及其在评估结直肠癌中的预后价值。
Ann Surg. 2000 Jan;231(1):11-24. doi: 10.1097/00000658-200001000-00003.
3
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.尿激酶型纤溶酶原激活物受体在结直肠肿瘤中的表达
Gut. 1998 Dec;43(6):798-805. doi: 10.1136/gut.43.6.798.
4
Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).肿瘤坏死因子α(TNF-α)对培养的卵巢癌细胞的自分泌自我清除作用。
Br J Cancer. 1998 Oct;78(7):862-70. doi: 10.1038/bjc.1998.594.
5
Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro.通过体外跨内皮侵袭系统建立的HT1080纤维肉瘤细胞的高转移变体对IV型胶原酶的增强作用。
Clin Exp Metastasis. 1998 Apr;16(3):267-74. doi: 10.1023/a:1006549026787.
6
Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.纤溶酶原激活的改变与结直肠腺瘤中上皮细胞发育异常分级相关。
Br J Cancer. 1998;77(2):297-304. doi: 10.1038/bjc.1998.46.
7
Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.滑膜组织中的纤溶酶原激活:正常关节、骨关节炎关节和类风湿关节炎关节之间的差异
Ann Rheum Dis. 1997 Sep;56(9):550-7. doi: 10.1136/ard.56.9.550.
8
In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.尿激酶/纤溶酶系统的原位基质表达与大肠腺瘤中的上皮发育异常相关。
Am J Pathol. 1997 Jan;150(1):283-95.
9
Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?纤溶酶原激活物抑制剂-1是控制尿激酶受体介导的细胞黏附和释放的分子开关吗?
J Cell Biol. 1996 Sep;134(6):1563-71. doi: 10.1083/jcb.134.6.1563.